Replies to post #73268 on NorthWest Biotherapeutics Inc (NWBO)

[f3tt3f]

And lots of new posters being very excited on our behalf.
So I can help but feel sceptical about these moves.
Hopefully I'm proven wrong

[md1225]

Considering we have a registrational PIII trial with over 300 patients dosed and followed for over a year since last patient enrolled, I'd say multiply by ten todays market cap and we'd be at fair value pending read out.